Garipalli Vivek 4
4 · CLOVER HEALTH INVESTMENTS, CORP. /DE · Filed Jan 10, 2025
Insider Transaction Report
Form 4
Garipalli Vivek
Director10% Owner
Transactions
- Exercise/Conversion
Class A Common Stock
2025-01-07+1,670,965→ 3,080,232 total - Exercise/Conversion
Restricted Stock Unit
2025-01-07−3,342,698→ 3,342,699 total→ Class B Common Stock (3,342,698 underlying) - Tax Payment
Class A Common Stock
2025-01-07$3.60/sh−1,670,965$6,015,474→ 1,409,267 total - Exercise/Conversion
Class B Common Stock
2025-01-07+3,342,698→ 8,575,308 total→ Class A Common Stock (3,342,698 underlying) - Exercise/Conversion
Class B Common Stock
2025-01-07−1,670,965→ 6,904,343 total→ Class A Common Stock (1,670,965 underlying)
Holdings
- 75,694,143(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (75,694,143 underlying) - 2,062,265(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (2,062,265 underlying) - 5,645,934(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (5,645,934 underlying) - 182,201(indirect: By LLC)
Class B Common Stock
→ Class A Common Stock (182,201 underlying)
Footnotes (4)
- [F1]The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.
- [F2]On January 7, 2025, 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,671,733 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,670,695 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.
- [F3]Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vests in equal installments on the first five anniversaries of January 7, 2021.
- [F4]The Reporting Person serves as the sole manager of each of NJ Healthcare Investments, LLC, Titus Ventures, LLC, Caesar Ventures, LLC and Caesar Clover, LLC.